<p>资金雄厚的投资者对百时美施贵宝（NYSE: BMY）采取了看涨的态度，这一点市场参与者不应忽视。我们在 Benzinga 对公共期权记录的跟踪揭示了今天这一重要举动。这些投资者的身份仍然未知，但在 BMY 中如此大规模的举动通常暗示着一些重大事件即将发生。</p>
<p>我们今天的观察中发现，Benzinga 的期权扫描仪突出了百时美施贵宝的 9 个非凡期权活动。这种活动水平是异常的。</p>
<p>这些重量级投资者的整体情绪分歧，55% 看涨，22% 看跌。在这些显著的期权中，有 2 个看跌期权，总计 924,240 美元，7 个看涨期权，总计 366,072 美元。</p>
<h3>预测价格目标</h3>
<p>根据交易活动，显著投资者的目标价格区间为百时美施贵宝在最近三个月内的 25.0 至 52.5 美元。</p>
<h3>成交量与未平仓合约发展</h3>
<p>在今天的交易环境中，百时美施贵宝的期权平均未平仓合约为 1396.11，总成交量达到 4,025.00。附图描绘了过去 30 天内百时美施贵宝高价值交易的看涨和看跌期权的成交量和未平仓合约的变化。</p>
<h3>百时美施贵宝看涨和看跌期权成交量：30 天概览</h3>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767376873_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="期权看涨图表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767376873_0.png"/></p>
<h3>值得注意的期权活动：</h3>
<table>
<thead>
<tr>
<th><strong>符号</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价</strong></th>
<th><strong>总交易价格</strong></th>
<th><strong>未平仓合约</strong></th>
<th><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BMY</td>
<td>看跌</td>
<td>交易</td>
<td>看涨</td>
<td>12/15/28</td>
<td>$4.95</td>
<td>$4.05</td>
<td>$4.35</td>
<td>$40.00</td>
<td>$863.0K</td>
<td>2</td>
<td>1.9K</td>
</tr>
<tr>
<td>BMY</td>
<td>看涨</td>
<td>扫描</td>
<td>看涨</td>
<td>09/18/26</td>
<td>$12.0</td>
<td>$11.85</td>
<td>$12.0</td>
<td>$43.00</td>
<td>$122.4K</td>
<td>620</td>
<td>105</td>
</tr>
<tr>
<td>BMY</td>
<td>看跌</td>
<td>交易</td>
<td>看跌</td>
<td>06/18/26</td>
<td>$0.36</td>
<td>$0.23</td>
<td>$0.34</td>
<td>$40.00</td>
<td>$61.2K</td>
<td>7.6K</td>
<td>1.8K</td>
</tr>
<tr>
<td>BMY</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>12/15/28</td>
<td>$24.35</td>
<td>$23.25</td>
<td>$24.1</td>
<td>$30.00</td>
<td>$48.2K</td>
<td>5</td>
<td>20</td>
</tr>
<tr>
<td>BMY</td>
<td>看涨</td>
<td>交易</td>
<td>中性</td>
<td>01/16/26</td>
<td>$28.7</td>
<td>$27.7</td>
<td>$28.2</td>
<td>$25.00</td>
<td>$45.1K</td>
<td>971</td>
<td>16</td>
</tr>
</tbody>
</table>
<h3>关于百时美施贵宝</h3>
<p>百时美施贵宝发现、开发并销售用于各种治疗领域的药物，如心血管、癌症和免疫疾病。百时美的一个关键焦点是免疫肿瘤学，该公司在药物开发方面处于领先地位。百时美近 70% 的总销售额来自美国，显示出对美国市场的依赖程度高于大多数同行。</p>
<h3>百时美施贵宝的当前市场地位</h3>
<ul>
<li>在 3,536,753 的交易量下，BMY 的价格下跌了 -0.64%，达到 53.59 美元。</li>
<li>当前 RSI 值表明该股票可能接近超买状态。</li>
<li>下一次财报预计在 34 天后发布。</li>
</ul>
<h3>专家对百时美施贵宝的看法</h3>
<p>在过去一个月中，5 位行业分析师分享了他们对该股票的见解，提出的平均目标价格为 53.6 美元。</p>
<p><strong>检测到异常期权活动：聪明资金在行动</strong></p>
<p>Benzinga Edge 的异常期权板块在潜在市场动向发生之前发现可能的市场推动者。查看大资金在您喜爱的股票上采取了什么头寸。点击此处访问。
* B of A Securities 的一位分析师将其评级上调至买入，目标价格为 61 美元。
* Wells Fargo 的一位分析师在评估中保持对百时美施贵宝的持平评级，目标价格为 55 美元。
* Scotiabank 的一位分析师继续对百时美施贵宝保持行业表现评级，目标价格为 53 美元。
* Morgan Stanley 的一位分析师维持对百时美施贵宝的减持评级，目标价格为 37 美元。
* Guggenheim 的一位分析师积极上调评级至买入，并将目标价格调整至 62 美元。</p>
<p>期权交易存在更高的风险和潜在的回报。精明的交易者通过不断学习、调整策略、监控多个指标以及密切关注市场动态来管理这些风险。通过 Benzinga Pro 的实时警报，随时了解百时美施贵宝的最新期权交易。</p>

百时美施贵宝

<p>百时美施贵宝 (NYSE:BMY) 最近出现了显著的看涨期权活动，55% 的投资者持看涨态度。该股票的预计价格区间在 25.0 美元到 52.5 美元之间。目前的交易量为 4,025，平均未平仓合约为 1,396。分析师们的意见各不相同，目标价格范围从 37 美元到 62 美元不等。该股票目前的价格为 53.59 美元，下跌 0.64%。下一个财报将在 34 天后发布。建议投资者关注期权交易风险和市场动态</p>

<p>Deep-pocketed investors have adopted a bullish approach towards Bristol-Myers Squibb (NYSE: BMY), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BMY usually suggests something big is about to happen.</p>
<div class="lb-trans"><p>资金雄厚的投资者对百时美施贵宝（NYSE: BMY）采取了看涨的态度，这一点市场参与者不应忽视。我们在 Benzinga 对公共期权记录的跟踪揭示了今天这一重要举动。这些投资者的身份仍然未知，但在 BMY 中如此大规模的举动通常暗示着一些重大事件即将发生。</p>
</div><p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Bristol-Myers Squibb. This level of activity is out of the ordinary.</p>
<div class="lb-trans"><p>我们今天的观察中发现，Benzinga 的期权扫描仪突出了百时美施贵宝的 9 个非凡期权活动。这种活动水平是异常的。</p>
</div><p>The general mood among these heavyweight investors is divided, with 55% leaning bullish and 22% bearish. Among these notable options, 2 are puts, totaling $924,240, and 7 are calls, amounting to $366,072.</p>
<div class="lb-trans"><p>这些重量级投资者的整体情绪分歧，55% 看涨，22% 看跌。在这些显著的期权中，有 2 个看跌期权，总计 924,240 美元，7 个看涨期权，总计 366,072 美元。</p>
</div><h3>Projected Price Targets</h3>
<div class="lb-trans"><h3>预测价格目标</h3>
</div><p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $25.0 to $52.5 for Bristol-Myers Squibb over the recent three months.</p>
<div class="lb-trans"><p>根据交易活动，显著投资者的目标价格区间为百时美施贵宝在最近三个月内的 25.0 至 52.5 美元。</p>
</div><h3>Volume &amp; Open Interest Development</h3>
<div class="lb-trans"><h3>成交量与未平仓合约发展</h3>
</div><p>In today's trading context, the average open interest for options of Bristol-Myers Squibb stands at 1396.11, with a total volume reaching 4,025.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Bristol-Myers Squibb, situated within the strike price corridor from $25.0 to $52.5, throughout the last 30 days.</p>
<div class="lb-trans"><p>在今天的交易环境中，百时美施贵宝的期权平均未平仓合约为 1396.11，总成交量达到 4,025.00。附图描绘了过去 30 天内百时美施贵宝高价值交易的看涨和看跌期权的成交量和未平仓合约的变化。</p>
</div><h3>Bristol-Myers Squibb Call and Put Volume: 30-Day Overview</h3>
<div class="lb-trans"><h3>百时美施贵宝看涨和看跌期权成交量：30 天概览</h3>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767376873_0.png" alt="Options Call Chart" original-src="https://www.benzinga.com/files/images/story/2026/1767376873_0.png"/></p>
<h3>Noteworthy Options Activity:</h3>
<div class="lb-trans"><h3>值得注意的期权活动：</h3>
</div><table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BMY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/15/28</td>
<td>$4.95</td>
<td>$4.05</td>
<td>$4.35</td>
<td>$40.00</td>
<td>$863.0K</td>
<td>2</td>
<td>1.9K</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$12.0</td>
<td>$11.85</td>
<td>$12.0</td>
<td>$43.00</td>
<td>$122.4K</td>
<td>620</td>
<td>105</td>
</tr>
<tr>
<td>BMY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$0.36</td>
<td>$0.23</td>
<td>$0.34</td>
<td>$40.00</td>
<td>$61.2K</td>
<td>7.6K</td>
<td>1.8K</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/15/28</td>
<td>$24.35</td>
<td>$23.25</td>
<td>$24.1</td>
<td>$30.00</td>
<td>$48.2K</td>
<td>5</td>
<td>20</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$28.7</td>
<td>$27.7</td>
<td>$28.2</td>
<td>$25.00</td>
<td>$45.1K</td>
<td>971</td>
<td>16</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>符号</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价</strong></th>
<th><strong>总交易价格</strong></th>
<th><strong>未平仓合约</strong></th>
<th><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BMY</td>
<td>看跌</td>
<td>交易</td>
<td>看涨</td>
<td>12/15/28</td>
<td>$4.95</td>
<td>$4.05</td>
<td>$4.35</td>
<td>$40.00</td>
<td>$863.0K</td>
<td>2</td>
<td>1.9K</td>
</tr>
<tr>
<td>BMY</td>
<td>看涨</td>
<td>扫描</td>
<td>看涨</td>
<td>09/18/26</td>
<td>$12.0</td>
<td>$11.85</td>
<td>$12.0</td>
<td>$43.00</td>
<td>$122.4K</td>
<td>620</td>
<td>105</td>
</tr>
<tr>
<td>BMY</td>
<td>看跌</td>
<td>交易</td>
<td>看跌</td>
<td>06/18/26</td>
<td>$0.36</td>
<td>$0.23</td>
<td>$0.34</td>
<td>$40.00</td>
<td>$61.2K</td>
<td>7.6K</td>
<td>1.8K</td>
</tr>
<tr>
<td>BMY</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>12/15/28</td>
<td>$24.35</td>
<td>$23.25</td>
<td>$24.1</td>
<td>$30.00</td>
<td>$48.2K</td>
<td>5</td>
<td>20</td>
</tr>
<tr>
<td>BMY</td>
<td>看涨</td>
<td>交易</td>
<td>中性</td>
<td>01/16/26</td>
<td>$28.7</td>
<td>$27.7</td>
<td>$28.2</td>
<td>$25.00</td>
<td>$45.1K</td>
<td>971</td>
<td>16</td>
</tr>
</tbody>
</table>
</div><h3>About Bristol-Myers Squibb</h3>
<div class="lb-trans"><h3>关于百时美施贵宝</h3>
</div><p>Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.</p>
<div class="lb-trans"><p>百时美施贵宝发现、开发并销售用于各种治疗领域的药物，如心血管、癌症和免疫疾病。百时美的一个关键焦点是免疫肿瘤学，该公司在药物开发方面处于领先地位。百时美近 70% 的总销售额来自美国，显示出对美国市场的依赖程度高于大多数同行。</p>
</div><h3>Present Market Standing of Bristol-Myers Squibb</h3>
<div class="lb-trans"><h3>百时美施贵宝的当前市场地位</h3>
</div><ul>
<li>With a trading volume of 3,536,753, the price of BMY is down by -0.64%, reaching $53.59.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 34 days from now.</li>
</ul>
<div class="lb-trans"><ul>
<li>在 3,536,753 的交易量下，BMY 的价格下跌了 -0.64%，达到 53.59 美元。</li>
<li>当前 RSI 值表明该股票可能接近超买状态。</li>
<li>下一次财报预计在 34 天后发布。</li>
</ul>
</div><h3>Expert Opinions on Bristol-Myers Squibb</h3>
<div class="lb-trans"><h3>专家对百时美施贵宝的看法</h3>
</div><p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $53.6.</p>
<div class="lb-trans"><p>在过去一个月中，5 位行业分析师分享了他们对该股票的见解，提出的平均目标价格为 53.6 美元。</p>
</div><p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<div class="lb-trans"><p><strong>检测到异常期权活动：聪明资金在行动</strong></p>
</div><p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
* An analyst from B of A Securities upgraded its action to Buy with a price target of $61.
* Consistent in their evaluation, an analyst from Wells Fargo keeps a Equal-Weight rating on Bristol-Myers Squibb with a target price of $55.
* An analyst from Scotiabank persists with their Sector Perform rating on Bristol-Myers Squibb, maintaining a target price of $53.
* Maintaining their stance, an analyst from Morgan Stanley continues to hold a Underweight rating for Bristol-Myers Squibb, targeting a price of $37.
* In a positive move, an analyst from Guggenheim has upgraded their rating to Buy and adjusted the price target to $62.</p>
<div class="lb-trans"><p>Benzinga Edge 的异常期权板块在潜在市场动向发生之前发现可能的市场推动者。查看大资金在您喜爱的股票上采取了什么头寸。点击此处访问。
* B of A Securities 的一位分析师将其评级上调至买入，目标价格为 61 美元。
* Wells Fargo 的一位分析师在评估中保持对百时美施贵宝的持平评级，目标价格为 55 美元。
* Scotiabank 的一位分析师继续对百时美施贵宝保持行业表现评级，目标价格为 53 美元。
* Morgan Stanley 的一位分析师维持对百时美施贵宝的减持评级，目标价格为 37 美元。
* Guggenheim 的一位分析师积极上调评级至买入，并将目标价格调整至 62 美元。</p>
</div><p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bristol-Myers Squibb options trades with real-time alerts from Benzinga Pro.</p>
<div class="lb-trans"><p>期权交易存在更高的风险和潜在的回报。精明的交易者通过不断学习、调整策略、监控多个指标以及密切关注市场动态来管理这些风险。通过 Benzinga Pro 的实时警报，随时了解百时美施贵宝的最新期权交易。</p>
</div>

解读百时美施贵宝的期权活动：整体情况如何？